SEARCH:      Monitor Keywords |  Custom RSS

Organic compounds -- part of the class 532-570 series January USPTO class listing 01/08

20080027231 - High stability diionic liquid salts: The present invention relates to diionic liquid salts of dicationic or dianionic molecules, as well as solvents comprising such diionic liquids and the use of such diionic liquids as the stationary phase in a gas chromatographic column.... Agent: Harness, Dickey, & Pierce, P.l.c

20080027232 - Boron complexation strategy for use in manipulating 1-acyldipyrromethanes: A method of making a metal complex comprises combining a 1-monoacyldipyrromethane with a compound of the formula R1R2MX, wherein M is boron, R1 and R2 are each independently organic substituents; and X is an anion leaving group; to produce a metal complex of the formula DMR1R2 wherein DH is a... Agent: Myers Bigel Sibley & Sajovec

20080027233 - Process for the preparation of alkyl 5-(dicarboximido) levulinate and alkyl 4-oxopentenoate: A method of manufacturing esters of dicarboxyimidolevulinic acid and alkyl trans-4-oxo-2-pentenoate. This method includes two reaction steps, wherein the first step of said two reaction steps is a bromination of alkyl-levulinate, to obtain alkyl-(3 and 5)-bromolevulinate, and the second step of said two reaction steps is a synthesis of esters... Agent: Merchant & Gould PC

20080021221 - Method for producing aminothiazole derivative and production intermediate: Provided is a method for selectively demethylating a 2-methoxy group. Specifically provided is a production method of a compound represented by formula (7) below through the following reactions... Agent: Oblon, Spivak, Mcclelland Maier & Neustadt, P.C.

20080021222 - Processes for preparing biaryl ureas and analogs thereof: The present invention relates to processes for preparing biaryl ureas derivatives and analogs thereof. The invention also provides compounds useful as intermediates in the processes of the present invention. The process is useful for preparing compounds that inhibit IMPDH.... Agent: Vertex Pharmaceuticals Inc.

20080021223 - Colorant-containing curable composition, color filter using the composition, and method for manufacturing the same: In Formula (I), R1 and R2 each independently represent H, an alkyl group, an alkenyl group, an aryl group, or an aralkyl group. R1 and R2 may be formed into a heterocycle together with a jointly bonded nitrogen atom. R3 represents a halogen atom, a trihalomethyl group, an alkoxy group,... Agent: Sughrue Mion, PLLC

20080021224 - Supports for oligomer synthesis: Universal linkers, their facile processes of manufacture and methods of using the same are provided.... Agent: Woodcock Washburn LLP

20080021225 - Process for the synthesis of peptides containing a 4-hydroxy-proline substructure: i

20080015357 - Process for the preparation of boronic acids and derivatives: A process for the preparation of a 4,4-dimethyl-2-phenyl-oxazoline boronic derivative (VII) by metallation of 4,4-dimethyl-2-phenyl-oxazoline with a Grignard reagent and its use in the preparation of 2-carboxybenzene-boronic acid, or a salt thereof, and recovery of the latter.... Agent: Griffin & Szipl, PC

20080015358 - Fluorination process of protected aminothiazole: A process for the production of fluorinated compound formula (I) comprising fluorination of a protected aminothiazole. Compounds formula (I) are useful in the preparation of activators of glucokinase.... Agent: Eli Lilly & Company

20080015359 - Process for the preparation of telmisartan: An improved process for the preparation of telmisartan, or a pharmaceutically acceptable salt thereof, comprises subjecting 1H-Benzimidazole-2-n-propyl-4-methyl-6-(1′-methyl benzimidazole-2+yl)] of formula (II), and methyl-4-(bromomethyl)biphenyl-2-carboxylate of formula (III) to condensation and hydrolysis in a single step:... Agent: Conley Rose, P.C.

20080015360 - Novel compounds:

20080015361 - Methods and systems for increasing production of equilibrium reactions: Methods and systems for increasing the production of equilibrium reactions are described. In some embodiments, a method comprises removing enzymes from a reaction mixture once equilibrium is achieved, selectively re-adding enzymes and reactants for driving the product-forming reaction to product, and optionally recycling stabilized intermediates, by-products and/or co-products back into... Agent: Fish & Richardson P.C.

20080009634 - Process for synthesizing beta-lactamase inhibitor intermediates: P

20080009635 - One-pot process for the preparation of antiemetic agent, 1,2,3,9-tetrahydro-9-methyl-3[(2-methyl)-1h-imidazole-1-yl)methyl]-4h-carbazol-4-o: A one-pot industrial process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazole-1-yl)methyl]-4H-carbazol-4-one of Formula-(I) from 1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one of Formula-(IV) involves reaction of Formula (IV) with HNR1R2 salt and paraformaldehyde, where R1,R2 are independently alkyl groups or together forms a cyclic alkyl group, in a solvent system of acetic acid and hydrocarbon solvent to form a crude... Agent: Blank Rome LLP

20080009636 - Nitrons carrying a positive charge and usable in trapping free radicals, especially the superoxide radical: The present invention involves new nitrons carrying a positive charge, useful in trapping of free radicals and especially the superoxide radical, of general formula:... Agent: Lackenbach Siegel, LLP

20080009637 - Preparation of n-protected-3-pyrrolidine-lactam substituted phosphonium salts: New process for the preparation of bipyrrolidinyl compounds of formula I wherein * signifies an asymmetric centre with an (R) or (S) configuration and X represents chlorine, bromine or iodine. The compounds of formula I are important building blocks for the production of useful products in the chemical and in... Agent: Gibbons P.C.

20080009638 - Process for the preparation of 2-oxo-1-pyrrolidine derivatives: w

20080009639 - Preparation of oseltamivir phosphate (tamiflu) and intermediates starting from d-glucose or d-xylose: Novel processes for the preparation of the anti-viral agent, Oseltamivir Phosphate and novel intermediates prepared in such processes. The novel processes use as starting materials D-glucose or D-xylose in the preparation of Oseltamivir Phosphate.... Agent: Ivor M. Hughes, Barrister & Solicitor, Patent & Trademark Agents